0001209191-20-050292.txt : 20200914
0001209191-20-050292.hdr.sgml : 20200914
20200914163936
ACCESSION NUMBER: 0001209191-20-050292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200910
FILED AS OF DATE: 20200914
DATE AS OF CHANGE: 20200914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEPORE PATRICK G
CENTRAL INDEX KEY: 0001055404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 201173594
MAIL ADDRESS:
STREET 1: 17-17 ROUTE 208 N
CITY: FAIRLAWN
STATE: NJ
ZIP: 07410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VYNE Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics Inc.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-10
0
0001566044
VYNE Therapeutics Inc.
VYNE
0001055404
LEPORE PATRICK G
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER
NJ
08807
1
0
0
0
Stock Options
1.46
2020-09-10
4
A
0
45000
0.00
A
2030-09-10
Common Stock
45000
45000
D
The option will vest and become exercisable as to 1/3rd of the shares subject to the option on each annual anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
/s/ Mutya Harsch, attorney-in-fact for Patrick LePore
2020-09-14